Cargando…
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
Estrogen receptor (ER) has a crucial role in normal breast development and is expressed in the most common breast cancer subtypes. Importantly, its expression is very highly predictive for response to endocrine therapy. Current endocrine therapies for ER-positive breast cancers target ER function at...
Autores principales: | Shao, Wenlin, Brown, Myles |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314456/ https://www.ncbi.nlm.nih.gov/pubmed/14680484 http://dx.doi.org/10.1186/bcr742 |
Ejemplares similares
-
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
por: Xiao, Tengfei, et al.
Publicado: (2018) -
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
por: Litzenburger, Beate C., et al.
Publicado: (2014) -
Estrogen receptor‐low breast cancer: Biology chaos and treatment paradox
por: Yu, Ke‐Da, et al.
Publicado: (2021) -
Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
por: Bronte, Giuseppe, et al.
Publicado: (2018) -
Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer
por: Datta, Jharna, et al.
Publicado: (2022)